Skip to main content

Table 2 Stool microbiology and parasitology at admission

From: Lactobacillus caseistrain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]

  Placebo group N LGG group N P
Rotavirus 33 (39.3%) 84 22 (24.4%) 90 0.052
EPEC 12 (17.6%) 68 9 (13.2%) 68 0.635
Vibrio cholerae 7 (8.0%) 88 11 (12.4%) 89 0.471
Campylobacter sp. 6 (6.8%) 88 9 (10.1%) 89 0.605
Shigella sp. 9 (10.2%) 88 4 (4.5%) 89 0.241
Aeromonas sp. 2 (2.3%) 88 1 (1.1%) 89 0.992
Salmonella sp. 0 (0.0%) 88 1 (1.1%) 89 0.995
Negative microbiology 25 (36.8%) 68 32 (47.1%) 68 0.452
Cryptosporidium parvum 6 (7.0%) 86 2 (2.2%) 89 0.256
Giardia lambliae 2 (2.3%) 86 3 (3.4%) 89 0.969
Strongyloides stercolaris 1 (1.2%) 86 0 (0.0%) 89 0.986
Trichomonas sp. 0 (0.0%) 86 2 (2.2%) 89 0.492
Negative parasitology 77 (89.5%) 86 82 (92.1%) 89 0.738
Negative microbiology and parasitology 22 (35.5%) 62 30 (44.8%) 67 0.371
  1. No patients were found positive for the following parasites: Ascaris, Enterobius, Trichuris, E. hystolytica, Ancylostoma, Necator.
  2. ETEC identification was not done
  3. Values are n (%)